CN1681510A - Pde ⅳ抑制剂治疗血管生成的用途 - Google Patents

Pde ⅳ抑制剂治疗血管生成的用途 Download PDF

Info

Publication number
CN1681510A
CN1681510A CNA038215454A CN03821545A CN1681510A CN 1681510 A CN1681510 A CN 1681510A CN A038215454 A CNA038215454 A CN A038215454A CN 03821545 A CN03821545 A CN 03821545A CN 1681510 A CN1681510 A CN 1681510A
Authority
CN
China
Prior art keywords
pde
inhibitors
angiogenesis
activity
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038215454A
Other languages
English (en)
Chinese (zh)
Inventor
D·A·盖玛彻
D·P·宾加曼
M·A·考平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Research LLC
Original Assignee
Alcon Manufacturing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Manufacturing Ltd filed Critical Alcon Manufacturing Ltd
Publication of CN1681510A publication Critical patent/CN1681510A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA038215454A 2002-09-16 2003-09-11 Pde ⅳ抑制剂治疗血管生成的用途 Pending CN1681510A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41100102P 2002-09-16 2002-09-16
US60/411,001 2002-09-16

Publications (1)

Publication Number Publication Date
CN1681510A true CN1681510A (zh) 2005-10-12

Family

ID=31994234

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038215454A Pending CN1681510A (zh) 2002-09-16 2003-09-11 Pde ⅳ抑制剂治疗血管生成的用途

Country Status (14)

Country Link
US (3) US20040053939A1 (https=)
EP (1) EP1539174A4 (https=)
JP (1) JP2006501269A (https=)
KR (1) KR20050043923A (https=)
CN (1) CN1681510A (https=)
AR (1) AR041263A1 (https=)
AU (1) AU2003267161A1 (https=)
BR (1) BR0314364A (https=)
CA (1) CA2497192A1 (https=)
MX (1) MXPA05002146A (https=)
PL (1) PL374659A1 (https=)
TW (1) TW200412972A (https=)
WO (1) WO2004024085A2 (https=)
ZA (1) ZA200501477B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851247B1 (fr) * 2003-02-19 2007-06-29 Exonhit Therapeutics Sa Methodes et compositions pour le traitement de pathologies degeneratives oculaires
SI1755616T1 (sl) * 2004-04-08 2014-04-30 Eye Co Pty Ltd. Zdravljenje eksudativne retinopatije z mineralkortikoidi
WO2007056457A2 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
EP2117524B8 (en) * 2007-01-29 2019-09-25 National Research Council of Canada Use of catecholamines and related compounds as anti-angiogenic agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570579B1 (fr) * 1984-09-26 1987-01-09 Salomon Sa Dispositif de fermeture et de serrage d'une chaussure de ski a ouverture arriere
US4975537A (en) * 1985-10-23 1990-12-04 The Upjohn Company Δ9(11) -angiostatic steroids
US4771042A (en) * 1985-11-25 1988-09-13 The Upjohn Company Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
US5605914A (en) * 1993-07-02 1997-02-25 Celgene Corporation Imides
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
AU6823098A (en) * 1997-02-28 1998-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
US5866872A (en) * 1997-07-25 1999-02-02 Hypertherm, Inc. Plasma arc torch position control
DE19812515A1 (de) * 1998-03-21 1999-09-23 M & F Entw & Patentverwertungs Lamellenschleifwerkzeug
HK1042896A1 (zh) * 1998-09-29 2002-08-30 藤泽药品工业株式会社 吡啶并吡嗪化合物的新的盐及其结晶
US6740664B2 (en) * 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
US6326888B1 (en) * 1998-12-17 2001-12-04 Ching-Yung Wang Auxiliary safety warning light system for a vehicle
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis

Also Published As

Publication number Publication date
AU2003267161A1 (en) 2004-04-30
US20060014782A1 (en) 2006-01-19
MXPA05002146A (es) 2005-05-23
PL374659A1 (en) 2005-10-31
EP1539174A4 (en) 2006-10-25
WO2004024085A3 (en) 2004-04-29
KR20050043923A (ko) 2005-05-11
CA2497192A1 (en) 2004-03-25
TW200412972A (en) 2004-08-01
AR041263A1 (es) 2005-05-11
US20050277648A1 (en) 2005-12-15
BR0314364A (pt) 2005-07-19
ZA200501477B (en) 2006-10-25
WO2004024085A2 (en) 2004-03-25
US20040053939A1 (en) 2004-03-18
JP2006501269A (ja) 2006-01-12
EP1539174A2 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
JP2006512318A5 (https=)
JP2014198730A (ja) 眼の疾患、ならびに増殖および脈管形成応答に関連する疾患の処置に関する５，６，７−トリヒドロキシヘプタン酸およびアナログ
Chen et al. Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases
CN1681510A (zh) Pde ⅳ抑制剂治疗血管生成的用途
CN100431544C (zh) 用于治疗病理性眼血管生成的糖皮质激素制剂
US20040259765A1 (en) Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
US20080070855A1 (en) Treatment with anti-VEGF agents to prevent postoperative inflammation and angiogenesis in normal and diseased eyes
JP2007500250A5 (https=)
RU2411969C1 (ru) Способ лечения вторичной неоваскулярной глаукомы
Garg et al. Ophthalmologic Disease in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
EP2875811A1 (en) Use of dobesilate for treating ocular haemorrhages
RU2409401C1 (ru) Способ лечения вторичной неоваскулярной глаукомы
Rixon et al. A case of open angle glaucoma secondary to Posner-Schlossman Syndrome
ZA200509532B (en) Formulations or non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
First et al. Corneal Haze
CN1802151A (zh) 用于治疗病理性眼内血管生成的非甾体类抗炎药制剂
MX2008007884A (en) Use of anecortave acetate as an adjunct during filtration bleb surgery
HK1110768B (en) 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication